Recursion Pharmaceuticals Inc (RXRX)
$3.45+3.29%
Spriggl Score: Moderate— sign in to explore; full breakdown with Premium
Last 30 trading days
Spriggl AI Verdict
“Binary bet on AI drug discovery; strong cash cushion offsets high burn until clinical proof arrives.”
Sign up free to read the full investment thesis, bull case, bear case and what to watch.
About Recursion Pharmaceuticals Inc
Recursion Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in the decoding biology and chemistry by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery in the United State…
- Sector:
- Healthcare
- Industry:
- Biotechnology
- Market Cap:
- $1.7B
Recent dividends
No recent dividends recorded.
Get the full Spriggl analysis — free
A free Spriggl account gets you the screener, a watchlist, AI verdicts and a free full report every day — across Recursion Pharmaceuticals Inc and 1,500+ UK and US stocks. The full score breakdown and AI analysis come with Premium.
Start free